Evotec SE Share Price Deutsche Boerse AG
Stocks
EVT
DE0005664809
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
06:50:18 07/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.901 EUR | -6.60% |
|
-9.69% | -48.10% |
| 06/10 | Investors seek stocks in diagnostics and laboratory sector | DP |
| 06/10 | Frankfurt Stocks Open Higher: Dax Rises After Positive Signals From US | DP |
| Market Cap | 52Cr 59Cr 49Cr 44Cr 84Cr 5.67TCr 84Cr 586.96Cr 228.29Cr 2.89TCr 220.82Cr 216.09Cr 9.3TCr | P/E 2026 * |
-2.3x | P/E 2027 * | -6.83x |
|---|---|---|---|---|---|
| Enterprise Value | 67Cr 75Cr 62Cr 56Cr 106.54Cr 7.22TCr 107.31Cr 747.52Cr 290.74Cr 3.68TCr 281.23Cr 275.19Cr 12TCr | EV / Sales 2026 * |
1.11x | EV / Sales 2027 * | 0.95x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| EVT | Delayed | |
CBOE
| EVTd | Real-time | |
|
Tradegate
| EVT | Real-time | |
|
Börse Stuttgart
| EVT | Delayed | |
|
Boerse Muenchen
| EVT | Real-time | |
|
Deutsche Boerse AG
| EVT | Delayed | |
|
Bulgaria S.E.
| EVT | End-of-day quote | |
|
London S.E.
| 0IRF | Delayed | |
|
OTC Markets
| EVOTF | Delayed | |
|
Borsa Italiana
| 1EVT | End-of-day quote | |
|
Wiener Boerse
| EVT | End-of-day quote | |
|
CBOE
| 0IRF | Real-time | |
|
Swiss Exchange
| EVT | Delayed |
Last Transcript: Evotec SE
| 1 day | -6.60% | ||
| 1 week | -9.69% | ||
| Current month | -9.69% | ||
| 1 month | -10.82% | ||
| 3 months | -44.86% | ||
| 6 months | -36.77% | ||
| Current year | -48.10% |
| 1 week | 2.83 |  | 3.11 |
| 1 month | 2.73 | | 3.19 |
| Current year | 2.73 | | 6.66 |
| 1 year | 2.73 | | 7.49 |
| 3 years | 2.73 | | 21.7 |
| 5 years | 2.73 | | 45.43 |
| 10 years | 2.73 | | 45.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01/07/2024 | |
| Director of Finance/CFO | - | 01/05/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 19/06/2019 |
| Director/Board Member | 64 | 01/06/2021 | |
Duncan McHale
BRD | Director/Board Member | 59 | 10/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.60% | -9.69% | - | - | 59Cr | |
| +4.16% | +4.16% | +49.37% | +94.17% | 7.47TCr | |
| -0.29% | -1.70% | +22.59% | +78.24% | 5.88TCr | |
| +0.14% | +0.66% | +7.18% | +34.97% | 4.84TCr | |
| -3.76% | -2.25% | +329.09% | +698.20% | 4.28TCr | |
| -2.30% | -3.35% | +26.81% | +30.88% | 4.28TCr | |
| +0.31% | -0.68% | +5.30% | +108.64% | 4.12TCr | |
| -0.11% | +1.96% | +9.19% | +52.66% | 3.11TCr | |
| -2.07% | +1.16% | +35.00% | +26.28% | 3.03TCr | |
| -1.96% | -2.88% | -8.97% | -13.92% | 2.4TCr | |
| Average | -1.25% | -0.25% | +52.84% | +123.35% | 4.38TCr | |
| Weighted average by Cap. | -0.16% | -0.54% | +55.69% | +129.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60Cr 68Cr 56Cr 51Cr 96Cr 6.53TCr 97Cr 675.37Cr 262.68Cr 3.33TCr 254.08Cr 248.63Cr 11TCr | 72Cr 82Cr 68Cr 61Cr 115.99Cr 7.86TCr 116.83Cr 813.86Cr 316.54Cr 4.01TCr 306.18Cr 299.62Cr 13TCr |
| Net income | -22Cr -25Cr -21Cr -19Cr -36Cr -2.41TCr -36Cr -249.51Cr -97Cr -1.23TCr -94Cr -92Cr -3.95TCr | -4.83Cr -5.44Cr -4.52Cr -4.09Cr -7.73Cr -523.97Cr -7.79Cr -54Cr -21Cr -267.3Cr -20Cr -20Cr -859.29Cr |
| Net Debt | 14Cr 16Cr 13Cr 12Cr 23Cr 1.55TCr 23Cr 160.56Cr 62Cr 791.36Cr 60Cr 59Cr 2.54TCr | 16Cr 18Cr 15Cr 14Cr 26Cr 1.76TCr 26Cr 182.27Cr 71Cr 898.37Cr 69Cr 67Cr 2.89TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | €2.834 | -8.76% | 1,900 |
| 06/26/06 | €3.106 | +5.72% | 2,640 |
| 05/26/05 | €2.938 | +0.41% | 3,120 |
| 02/26/02 | €2.926 | -5.12% | 1,550 |
| 01/26/01 | €3.084 | -1.72% | 8,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
Select your edition
All financial news and data tailored to specific country editions
